THE INVESTOR CENTRE
T
he UK equity market made a
steady recovery from the Brexit
sell-o , albeit primarily driven by
those sectors and stocks that were
obvious bene ciaries from the
weakness of sterling.However, as the
realisation that the economy had
merely paused post the vote, stories of
imminent recession lost credibility and
domestic stocks began to recover.
Overseas investors, encouraged by
the market fall and currency weakness,
began to transact on UK stocks and
assets, helping con dence.This leaves
the UKmarket in calmer waters but
Brexit has yet to happen and it would
be realistic to expect sterner tests ahead.
Although our transaction activity
was initially skewed towards picking
up opportunities after the sharp
sell-o in domestic stocks, latterly it
has become more broadly
based.Ofnote has been our decision to
emphasise BP over Shell and increase
the holding, likewise forAviva among
our life assurance
holdings.Wesubscribed to the Melrose rights issue,
which has led to a signi cant increase
in the exposure here. Finally,we used
the share price strength, driven by
sterling’s weakness, to reduce holdings
in Pearson and Tate & Lyle.
G
lobal stocks started Q3 with a
post-Brexit rebound. Sterling
weakened against most major
currencies, though currency volatility
diminished through the quarter. In
local terms, emerging markets
outpaced the world,while the UK
outpaced developed market stocks.
Among our top contributors were
ABB andMicrosoft.Global
engineering companyABB reported
its seventh consecutive quarter of
operating margin improvement.
Microsoft is increasingly becoming
a cloud-based commercial software
provider – areas where it holds strong
positions and is growing rapidly.
The largest detractors wereTesco
and Progressive.The leading UK
grocery retailer still faces strong
competition from discounters, and
investments in lower prices should
lower the pace of margin expansion.
However, based on our estimation of
normalised pro tability, the shares
remain attractively valued.One of the
largest personal auto insurers in the
US, Progressive reported higher than
expected catastrophe losses but remains
one of the industry’s better operators.
Finally,we exited our positions in
Joy Global and Fanuc.
A
fter Q2’s focus on Brexit,
investors returned to global
issues: economic growth and company
earnings,US interest rates, central
bank stimulus,China and the
November presidential election. In
August, the Bank of England surprised
markets positively with a 0.25% cut in
rates and revived its QE programme.
Equity markets made progress,with
strong liquidity the major
driver.Wesawsome pro t-taking inbond markets
in September as investors worried that
central banks had run out of repower
for further monetary stimulus, and
that US interest rates might rise.This
was a quiet period in terms of activity
and we made no signi cant changes to
asset allocation. In the UK one of our
larger holdings,ARM, agreed to a
generous bid from Japan’s SoftBank,
which we added to in our Japanese
portfolio after underperformance.
Liquidity can drive equities higher in
the short term but valuations are more
important in the longer term and,
with the possible exception of Japan
and Emerging Markets, they look very
extended. Fiscal stimulus may replace
monetary stimulus,which would be
better for equities than bonds.
ARTEMIS
UK & International Income
Stocks have been broadly based
with BP and Aviva added to portfolio
ARTISAN PARTNERS
Global Managed
Global
ABB and Microsoft provide greatest
positive contribution to portfolio
AXA INVESTMENT
MANAGERS
AXA Framlington Managed
Balanced Managed
ARM’s purchase by SoftBank moves
the holding to Japanese portfolio
UK stocks continued
to recover, buoyedby
sterling’sweakness
UKbene ts frompost-
Brexit reboundhelped
byweakenedpound
Global issues return
to the investment
agenda
Dan O’Keefe, David Samra and
James Hamel
Richard Peirson
Adrian Frost
THE INVESTOR
|
29




